T1	Participants 144 235	patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.
T2	Participants 377 533	active rheumatoid arthritis (RA) in patients receiving a stable background regimen of methotrexate (MTX) who have an inadequate response to MTX monotherapy.
T3	Participants 590 623	patients with active RA (n = 507)
T4	Participants 1950 2035	CONCLUSION In patients with active RA in whom the response to MTX has been inadequate
